Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-04-01

AUTHORS

E Costello, M Munoz, E Buetti, P R A Meylan, H Diggelmann, M Thali

ABSTRACT

Genetic modification of T lymphocytes holds great potential for treatments of cancer, T cell disorders and AIDS. While in the past recombinant murine retroviruses were the vectors of choice for gene delivery to T cells, vectors based on lentiviruses can provide additional benefits. Here, we show that VSV-G pseudotyped HIV 1 vector particles delivering the enhanced green fluorescent protein (EGFP) efficiently transduce human T lymphocytes. Transduction efficiency was optimal when infection included centrifugation of cells with concentrated vector supernatant in the presence of Polybrene. In contrast to previous reports describing murine retrovirus-mediated gene transfer to T lymphocytes, fibronectin did not improve the transduction efficiency of the VSVG-pseudotyped HIV-1 particles. Similar gene transfer efficiencies were observed following stimulation of cells with PHA/IL-2 or anti-CD3i/CD28i antibodies, although greater transgene expression was observed in the latter case. Interestingly, production of vectors in the absence of the accessory proteins Vif, Vpr, Vpu and Nef was accompanied by a 50% decrease in transduction efficiency in activated T cells. Transduction of T cells that were not stimulated before infection was achieved. No transduction of non-prestimulated cells was observed with a GALV-pseudotyped murine retroviral vector. The requirement for accessory proteins in non-prestimulated cells was more pronounced. Our results have implications for lentiviral vector targeting of other cells of the hematopoietic system including stem cells. More... »

PAGES

596-604

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.gt.3301135

DOI

http://dx.doi.org/10.1038/sj.gt.3301135

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037289278

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10819575


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Green Fluorescent Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV-1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indicators and Reagents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Luminescent Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Costello", 
        "givenName": "E", 
        "id": "sg:person.0667260706.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667260706.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Munoz", 
        "givenName": "M", 
        "id": "sg:person.0661004565.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661004565.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buetti", 
        "givenName": "E", 
        "id": "sg:person.014742727005.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014742727005.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meylan", 
        "givenName": "P R A", 
        "id": "sg:person.01336350503.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diggelmann", 
        "givenName": "H", 
        "id": "sg:person.01127251017.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127251017.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Microbiology, University of Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thali", 
        "givenName": "M", 
        "id": "sg:person.0636677244.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636677244.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/38410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048288589", 
          "https://doi.org/10.1038/38410"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0925-5710(97)90114-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054664126", 
          "https://doi.org/10.1016/s0925-5710(97)90114-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt0997-871", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006020704", 
          "https://doi.org/10.1038/nbt0997-871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng1197-314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045816864", 
          "https://doi.org/10.1038/ng1197-314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4615-1995-9_3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051225285", 
          "https://doi.org/10.1007/978-1-4615-1995-9_3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-04-01", 
    "datePublishedReg": "2000-04-01", 
    "description": "Genetic modification of T lymphocytes holds great potential for treatments of cancer, T cell disorders and AIDS. While in the past recombinant murine retroviruses were the vectors of choice for gene delivery to T cells, vectors based on lentiviruses can provide additional benefits. Here, we show that VSV-G pseudotyped HIV 1 vector particles delivering the enhanced green fluorescent protein (EGFP) efficiently transduce human T lymphocytes. Transduction efficiency was optimal when infection included centrifugation of cells with concentrated vector supernatant in the presence of Polybrene. In contrast to previous reports describing murine retrovirus-mediated gene transfer to T lymphocytes, fibronectin did not improve the transduction efficiency of the VSVG-pseudotyped HIV-1 particles. Similar gene transfer efficiencies were observed following stimulation of cells with PHA/IL-2 or anti-CD3i/CD28i antibodies, although greater transgene expression was observed in the latter case. Interestingly, production of vectors in the absence of the accessory proteins Vif, Vpr, Vpu and Nef was accompanied by a 50% decrease in transduction efficiency in activated T cells. Transduction of T cells that were not stimulated before infection was achieved. No transduction of non-prestimulated cells was observed with a GALV-pseudotyped murine retroviral vector. The requirement for accessory proteins in non-prestimulated cells was more pronounced. Our results have implications for lentiviral vector targeting of other cells of the hematopoietic system including stem cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.gt.3301135", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "transduction efficiency", 
      "enhanced green fluorescent protein", 
      "production of vectors", 
      "HIV-1-derived lentiviral vectors", 
      "vector of choice", 
      "greater transgene expression", 
      "HIV-1 vector particles", 
      "similar gene transfer efficiency", 
      "gene transfer efficiency", 
      "gene transfer", 
      "gene delivery", 
      "murine retroviral vector", 
      "vector targeting", 
      "vector supernatants", 
      "recombinant murine retrovirus", 
      "transgene expression", 
      "lentiviral vectors", 
      "vector particles", 
      "presence of polybrene", 
      "genetic modification", 
      "retroviral vectors", 
      "great potential", 
      "green fluorescent protein", 
      "murine retrovirus", 
      "transfer efficiency", 
      "fluorescent protein", 
      "stem cells", 
      "efficiency", 
      "treatment of cancer", 
      "vector", 
      "particles", 
      "unstimulated T lymphocytes", 
      "VSVG", 
      "GALV", 
      "retroviruses", 
      "VSV", 
      "delivery", 
      "polybrene", 
      "targeting", 
      "transfer", 
      "lentivirus", 
      "cells", 
      "transduction", 
      "modification", 
      "requirements", 
      "PHA/IL", 
      "potential", 
      "centrifugation of cells", 
      "centrifugation", 
      "production", 
      "antibodies", 
      "system", 
      "protein", 
      "hematopoietic system", 
      "supernatant", 
      "HIV-1 particles", 
      "additional benefit", 
      "T-cell disorders", 
      "accessory proteins", 
      "accessory protein Vif", 
      "presence", 
      "results", 
      "latter case", 
      "previous reports", 
      "human T lymphocytes", 
      "benefits", 
      "contrast", 
      "fibronectin", 
      "expression", 
      "Vpr", 
      "decrease", 
      "choice", 
      "stimulation of cells", 
      "absence", 
      "treatment", 
      "infection", 
      "Vpu", 
      "cancer", 
      "report", 
      "T cells", 
      "cases", 
      "IL", 
      "T lymphocytes", 
      "Vif", 
      "Nef", 
      "cell disorders", 
      "lymphocytes", 
      "disorders", 
      "stimulation", 
      "implications", 
      "activated T cells", 
      "AIDS"
    ], 
    "name": "Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors", 
    "pagination": "596-604", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037289278"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.gt.3301135"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10819575"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.gt.3301135", 
      "https://app.dimensions.ai/details/publication/pub.1037289278"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_325.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.gt.3301135"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301135'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301135'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301135'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301135'


 

This table displays all metadata directly associated to this object as RDF triples.

260 TRIPLES      21 PREDICATES      135 URIs      122 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.gt.3301135 schema:about N07fdbfd5abae4c8e87ea43215dcf1f70
2 N2249a16cb1de4c9d9dbe607e8827e7ce
3 N24e14578eb534150ac77e57e9f03d170
4 N3c581acdb3d44c11bd209a1c8bd59be0
5 N5a7e1a8691d744cc8ef0ad9858a75076
6 N8a6b5732548f42ef9009d734a66cf6ff
7 N8c3d1e48af0144a38fb9d5b35f151a35
8 Nb901534a8c5740498f2677e26c5a1d78
9 Nd5378006182a4f9b95d8ecd7e9a14eb4
10 Nd930e1258f03472193503738fbd5f92e
11 Needf90daea6c4248bd2f946f85c04dbe
12 Nf0c186b7b069442f99cbe8fcfdf7806b
13 Nf1fa24b9e68f48388ac440cf5bbc280f
14 anzsrc-for:06
15 anzsrc-for:11
16 schema:author N63144d334d33474b9289c735adbc939d
17 schema:citation sg:pub.10.1007/978-1-4615-1995-9_3
18 sg:pub.10.1016/s0925-5710(97)90114-6
19 sg:pub.10.1038/38410
20 sg:pub.10.1038/nbt0997-871
21 sg:pub.10.1038/ng1197-314
22 schema:datePublished 2000-04-01
23 schema:datePublishedReg 2000-04-01
24 schema:description Genetic modification of T lymphocytes holds great potential for treatments of cancer, T cell disorders and AIDS. While in the past recombinant murine retroviruses were the vectors of choice for gene delivery to T cells, vectors based on lentiviruses can provide additional benefits. Here, we show that VSV-G pseudotyped HIV 1 vector particles delivering the enhanced green fluorescent protein (EGFP) efficiently transduce human T lymphocytes. Transduction efficiency was optimal when infection included centrifugation of cells with concentrated vector supernatant in the presence of Polybrene. In contrast to previous reports describing murine retrovirus-mediated gene transfer to T lymphocytes, fibronectin did not improve the transduction efficiency of the VSVG-pseudotyped HIV-1 particles. Similar gene transfer efficiencies were observed following stimulation of cells with PHA/IL-2 or anti-CD3i/CD28i antibodies, although greater transgene expression was observed in the latter case. Interestingly, production of vectors in the absence of the accessory proteins Vif, Vpr, Vpu and Nef was accompanied by a 50% decrease in transduction efficiency in activated T cells. Transduction of T cells that were not stimulated before infection was achieved. No transduction of non-prestimulated cells was observed with a GALV-pseudotyped murine retroviral vector. The requirement for accessory proteins in non-prestimulated cells was more pronounced. Our results have implications for lentiviral vector targeting of other cells of the hematopoietic system including stem cells.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N2a803a6b62104f3f9a72a5548119c16d
28 N64a3c84aea424995bcd3c526c4845a53
29 sg:journal.1105638
30 schema:keywords AIDS
31 GALV
32 HIV-1 particles
33 HIV-1 vector particles
34 HIV-1-derived lentiviral vectors
35 IL
36 Nef
37 PHA/IL
38 T cells
39 T lymphocytes
40 T-cell disorders
41 VSV
42 VSVG
43 Vif
44 Vpr
45 Vpu
46 absence
47 accessory protein Vif
48 accessory proteins
49 activated T cells
50 additional benefit
51 antibodies
52 benefits
53 cancer
54 cases
55 cell disorders
56 cells
57 centrifugation
58 centrifugation of cells
59 choice
60 contrast
61 decrease
62 delivery
63 disorders
64 efficiency
65 enhanced green fluorescent protein
66 expression
67 fibronectin
68 fluorescent protein
69 gene delivery
70 gene transfer
71 gene transfer efficiency
72 genetic modification
73 great potential
74 greater transgene expression
75 green fluorescent protein
76 hematopoietic system
77 human T lymphocytes
78 implications
79 infection
80 latter case
81 lentiviral vectors
82 lentivirus
83 lymphocytes
84 modification
85 murine retroviral vector
86 murine retrovirus
87 particles
88 polybrene
89 potential
90 presence
91 presence of polybrene
92 previous reports
93 production
94 production of vectors
95 protein
96 recombinant murine retrovirus
97 report
98 requirements
99 results
100 retroviral vectors
101 retroviruses
102 similar gene transfer efficiency
103 stem cells
104 stimulation
105 stimulation of cells
106 supernatant
107 system
108 targeting
109 transduction
110 transduction efficiency
111 transfer
112 transfer efficiency
113 transgene expression
114 treatment
115 treatment of cancer
116 unstimulated T lymphocytes
117 vector
118 vector of choice
119 vector particles
120 vector supernatants
121 vector targeting
122 schema:name Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors
123 schema:pagination 596-604
124 schema:productId N4f388b44bb384910a61c7bc21b13f2a6
125 Na433063240674394a1fdaf4740c1e095
126 Nf5f1e31e96204dd7b29fd3dbc368bfba
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037289278
128 https://doi.org/10.1038/sj.gt.3301135
129 schema:sdDatePublished 2022-10-01T06:31
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher Ne5caebd963b4425681f8e0c2cad05942
132 schema:url https://doi.org/10.1038/sj.gt.3301135
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N07fdbfd5abae4c8e87ea43215dcf1f70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Cell Line
138 rdf:type schema:DefinedTerm
139 N2249a16cb1de4c9d9dbe607e8827e7ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Gene Expression
141 rdf:type schema:DefinedTerm
142 N24e14578eb534150ac77e57e9f03d170 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name HIV-1
144 rdf:type schema:DefinedTerm
145 N2a803a6b62104f3f9a72a5548119c16d schema:issueNumber 7
146 rdf:type schema:PublicationIssue
147 N2c7262b15fd44a20b68bf15c0dfdde3e rdf:first sg:person.01336350503.09
148 rdf:rest N5a0c930af67d4df592f96a9079d1939d
149 N3c581acdb3d44c11bd209a1c8bd59be0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name T-Lymphocytes
151 rdf:type schema:DefinedTerm
152 N4f388b44bb384910a61c7bc21b13f2a6 schema:name pubmed_id
153 schema:value 10819575
154 rdf:type schema:PropertyValue
155 N5a0c930af67d4df592f96a9079d1939d rdf:first sg:person.01127251017.00
156 rdf:rest N7cfb21cd26d94d04bb58ea7df9e09310
157 N5a7e1a8691d744cc8ef0ad9858a75076 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Luminescent Proteins
159 rdf:type schema:DefinedTerm
160 N63144d334d33474b9289c735adbc939d rdf:first sg:person.0667260706.15
161 rdf:rest Na8b11c8acba2440a9d4b2313757bc2c4
162 N64a3c84aea424995bcd3c526c4845a53 schema:volumeNumber 7
163 rdf:type schema:PublicationVolume
164 N7cfb21cd26d94d04bb58ea7df9e09310 rdf:first sg:person.0636677244.50
165 rdf:rest rdf:nil
166 N8a6b5732548f42ef9009d734a66cf6ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Indicators and Reagents
168 rdf:type schema:DefinedTerm
169 N8c3d1e48af0144a38fb9d5b35f151a35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Genetic Engineering
171 rdf:type schema:DefinedTerm
172 Na433063240674394a1fdaf4740c1e095 schema:name doi
173 schema:value 10.1038/sj.gt.3301135
174 rdf:type schema:PropertyValue
175 Na8b11c8acba2440a9d4b2313757bc2c4 rdf:first sg:person.0661004565.06
176 rdf:rest Nb8047a39b9b84c60b6599d87efbd51ce
177 Nb8047a39b9b84c60b6599d87efbd51ce rdf:first sg:person.014742727005.28
178 rdf:rest N2c7262b15fd44a20b68bf15c0dfdde3e
179 Nb901534a8c5740498f2677e26c5a1d78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Green Fluorescent Proteins
181 rdf:type schema:DefinedTerm
182 Nd5378006182a4f9b95d8ecd7e9a14eb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Lymphocyte Activation
184 rdf:type schema:DefinedTerm
185 Nd930e1258f03472193503738fbd5f92e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Genetic Therapy
187 rdf:type schema:DefinedTerm
188 Ne5caebd963b4425681f8e0c2cad05942 schema:name Springer Nature - SN SciGraph project
189 rdf:type schema:Organization
190 Needf90daea6c4248bd2f946f85c04dbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Genetic Vectors
192 rdf:type schema:DefinedTerm
193 Nf0c186b7b069442f99cbe8fcfdf7806b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Humans
195 rdf:type schema:DefinedTerm
196 Nf1fa24b9e68f48388ac440cf5bbc280f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Transfection
198 rdf:type schema:DefinedTerm
199 Nf5f1e31e96204dd7b29fd3dbc368bfba schema:name dimensions_id
200 schema:value pub.1037289278
201 rdf:type schema:PropertyValue
202 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
203 schema:name Biological Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
206 schema:name Medical and Health Sciences
207 rdf:type schema:DefinedTerm
208 sg:journal.1105638 schema:issn 0969-7128
209 1476-5462
210 schema:name Gene Therapy
211 schema:publisher Springer Nature
212 rdf:type schema:Periodical
213 sg:person.01127251017.00 schema:affiliation grid-institutes:None
214 schema:familyName Diggelmann
215 schema:givenName H
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127251017.00
217 rdf:type schema:Person
218 sg:person.01336350503.09 schema:affiliation grid-institutes:None
219 schema:familyName Meylan
220 schema:givenName P R A
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09
222 rdf:type schema:Person
223 sg:person.014742727005.28 schema:affiliation grid-institutes:None
224 schema:familyName Buetti
225 schema:givenName E
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014742727005.28
227 rdf:type schema:Person
228 sg:person.0636677244.50 schema:affiliation grid-institutes:None
229 schema:familyName Thali
230 schema:givenName M
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636677244.50
232 rdf:type schema:Person
233 sg:person.0661004565.06 schema:affiliation grid-institutes:None
234 schema:familyName Munoz
235 schema:givenName M
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661004565.06
237 rdf:type schema:Person
238 sg:person.0667260706.15 schema:affiliation grid-institutes:None
239 schema:familyName Costello
240 schema:givenName E
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667260706.15
242 rdf:type schema:Person
243 sg:pub.10.1007/978-1-4615-1995-9_3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051225285
244 https://doi.org/10.1007/978-1-4615-1995-9_3
245 rdf:type schema:CreativeWork
246 sg:pub.10.1016/s0925-5710(97)90114-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054664126
247 https://doi.org/10.1016/s0925-5710(97)90114-6
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/38410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048288589
250 https://doi.org/10.1038/38410
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/nbt0997-871 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006020704
253 https://doi.org/10.1038/nbt0997-871
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/ng1197-314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045816864
256 https://doi.org/10.1038/ng1197-314
257 rdf:type schema:CreativeWork
258 grid-institutes:None schema:alternateName Institute of Microbiology, University of Lausanne, Switzerland
259 schema:name Institute of Microbiology, University of Lausanne, Switzerland
260 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...